Barakat syndrome revisited
Autor: | Owen M. Rennert, Amin J. Barakat, Margarita Raygada |
---|---|
Rok vydání: | 2018 |
Předmět: |
Male
0301 basic medicine medicine.medical_specialty Hypoparathyroidism Barakat syndrome Hearing Loss Sensorineural 030209 endocrinology & metabolism GATA3 Transcription Factor Disease Deafness Sensorineural deafness 03 medical and health sciences 0302 clinical medicine Genetics medicine OMIM : Online Mendelian Inheritance in Man Humans Family history Genetics (clinical) business.industry Genetic disorder medicine.disease Dermatology 030104 developmental biology Nephrosis Female Kidney Diseases Haploinsufficiency business |
Zdroj: | American Journal of Medical Genetics Part A. 176:1341-1348 |
ISSN: | 1552-4825 |
DOI: | 10.1002/ajmg.a.38693 |
Popis: | Barakat syndrome also known as HDR syndrome (Online Mendelian Inheritance in Man [OMIM] 146255), was first described by Barakat et al. in . It is a rare genetic disorder characterized by the triad of hypoparathyroidism "H," sensorineural deafness "D," and renal disease "R." The defect is caused by deletions in chromosome 10p14 or mutations in the GATA3 gene. Although the syndrome has been phenotypically defined by this triad the literature identifies cases with different components with, or without GATA3 defects making the definition of the syndrome confusing. We analyzed 180 cases and attempted to define the phenotype of the syndrome and suggest guidelines for diagnosis. We suggest that the diagnosis could be confirmed in patients who have all three components, and in those who have two components with a positive family history. GATA3 testing is optional to establish the diagnosis in these patients. The syndrome should be considered in patients with isolated "D" where other causes of "D" have been excluded and those with isolated "R," especially if there is family history of any of these components. In these instances, confirmatory GATA3 testing is indicated to confirm the diagnosis. In patients with nonsurgical "H," where "D" and "R" have been conclusively ruled out GATA3 studies are not needed as none of these patients were shown to be GATA3 haploinsufficient. Only 64.4% of patients in our review had "HDR." Some findings might have not been recognized or may could have appeared later in life, but it is evident that this syndrome is genotypically heterogeneous. |
Databáze: | OpenAIRE |
Externí odkaz: |